Archive · 4 Aug 2026
Encube Ethicals Files ₹3,000-Crore OFS IPO
Encube Ethicals is a company that makes special medicines.
It wants to sell some of its shares to the public.
The company has asked the Indian market regulator, SEBI, to let it do this.
The sale will bring money to the people who already own shares, not to the company itself.
The company is big, with factories in many countries, and it made a lot of money last year.
Encube Ethicals filed preliminary papers with SEBI for a ₹3,000 crore IPO.
The offer is an OFS, meaning only existing shareholders will sell shares.
Promoter Mehul Madhusudan Shah and shareholder Frontier Investment Holdings Pte. Ltd are selling shares.
The company, founded in 1995, serves 50 countries and has 1,684 employees.
FY26 revenue was ₹1,848.7 crore and net profit ₹436.7 crore.
- Who
- Encube Ethicals, promoter Mehul Madhusudan Shah, shareholder Frontier Investment Holdings Pte. Ltd
- What
- Filed preliminary papers with SEBI for a ₹3,000 crore OFS IPO
- When
- Filed on Friday (article date not specified)
- Where
- New Delhi; company headquartered in Mumbai
- Why
- To sell shares by promoters and existing shareholders, not to raise new capital
- Company
- Encube Ethicals
- IPO Size
- ₹3,000 crore
- Offer Type
- OFS
- Promoter
- Mehul Madhusudan Shah
- Shareholder
- Frontier Investment Holdings Pte. Ltd
- Lead Managers
- JM Financial, Axis Capital, Kotak Mahindra Capital
- Registrar
- MUFG Intime India
- Listing
- BSE and NSE
- FY26 Revenue
- ₹1,848.7 crore
- FY26 Net Profit
- ₹436.7 crore
